Paper36915194
Eukaryotic Initiation Factor 5A2 localizes to actively translating ribosomes to promote cancer cell protrusions and invasive capacity.
Martínez-Férriz A and 5 others. Cell Commun Signal, 2023. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Eukaryotic Initiation Factor 5A2 localizes to actively translating ribosomes to promote cancer cell protrusions and invasive capacity. Papers, record 36915194. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36915194
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Eukaryotic Initiation Factor 5A2 localizes to actively translating ribosomes to promote cancer cell protrusions and invasive capacity.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Non-Small-Cell Lung | Major topic |
| Lung Neoplasms | Major topic |
| Humans | |
| Mice | |
| Animals | |
| Ribosomes | |
| Peptide Initiation Factors | |
| Puromycin |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22722845 | A tumour suppressor network relying on the polyamine-hypusine axis. | Nature | 2012 | https://conductscience.org/library/papers/22722845 | PubMed |
| 2 | 27637266 | Localized translation regulates cell adhesion and transendothelial migration. | J Cell Sci | 2016 | https://conductscience.org/library/papers/27637266 | PubMed |
| 3 | 19424157 | Hypusine-containing protein eIF5A promotes translation elongation. | Nature | 2009 | https://conductscience.org/library/papers/19424157 | PubMed |
| 4 | 14166766 | PUROMYCIN INHIBITION OF PROTEIN SYNTHESIS: INCORPORATION OF PUROMYCIN INTO PEPTIDE CHAINS. | Proc Natl Acad Sci U S A | 1964 | https://conductscience.org/library/papers/14166766 | PubMed |
| 5 | 8347280 | Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation. | Biofactors | 1993 | https://conductscience.org/library/papers/8347280 | PubMed |
| 6 | 20112425 | Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma. | Hepatology | 2010 | https://conductscience.org/library/papers/20112425 | PubMed |
| 7 | 25979826 | The translation factor eIF5A and human cancer. | Biochim Biophys Acta | 2015 | https://conductscience.org/library/papers/25979826 | PubMed |
| 8 | 24923804 | Fertility and polarized cell growth depends on eIF5A for translation of polyproline-rich formins in Saccharomyces cerevisiae. | Genetics | 2014 | https://conductscience.org/library/papers/24923804 | PubMed |
| 9 | 11161802 | Human eIF5A2 on chromosome 3q25-q27 is a phylogenetically conserved vertebrate variant of eukaryotic translation initiation factor 5A with tissue-specific expression. | Genomics | 2001 | https://conductscience.org/library/papers/11161802 | PubMed |
| 10 | 29428664 | EIF5A1 promotes epithelial ovarian cancer proliferation and progression. | Biomed Pharmacother | 2018 | https://conductscience.org/library/papers/29428664 | PubMed |
| 11 | 34198671 | Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34198671 | PubMed |
| 12 | 7759117 | The eukaryotic cofactor for the human immunodeficiency virus type 1 (HIV-1) rev protein, eIF-5A, maps to chromosome 17p12-p13: three eIF-5A pseudogenes map to 10q23.3, 17q25, and 19q13.2. | Genomics | 1995 | https://conductscience.org/library/papers/7759117 | PubMed |
| 13 | 23322277 | Overexpression of CK20, MAP3K8 and EIF5A correlates with poor prognosis in early-onset colorectal cancer patients. | J Cancer Res Clin Oncol | 2013 | https://conductscience.org/library/papers/23322277 | PubMed |
| 14 | 31195692 | TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31195692 | PubMed |
| 15 | 20830705 | Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patients. | Int J Cancer | 2011 | https://conductscience.org/library/papers/20830705 | PubMed |
| 16 | 16519677 | Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells. | FEBS J | 2006 | https://conductscience.org/library/papers/16519677 | PubMed |
| 17 | 7961711 | Antiproliferative effects of inhibitors of deoxyhypusine synthase. Inhibition of growth of Chinese hamster ovary cells by guanyl diamines. | J Biol Chem | 1994 | https://conductscience.org/library/papers/7961711 | PubMed |
| 18 | 24250246 | Roles of eukaryotic initiation factor 5A2 in human cancer. | Int J Biol Sci | 2013 | https://conductscience.org/library/papers/24250246 | PubMed |
| 19 | 32605067 | Overexpression of EIF5A2 Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma. | Diagnostics (Basel) | 2020 | https://conductscience.org/library/papers/32605067 | PubMed |
| 20 | 26715760 | Structure of the hypusinylated eukaryotic translation factor eIF-5A bound to the ribosome. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/26715760 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41390489 | Inhibiting translation elongation by reducing eIF5A activity induces feedback inhibition of initiation, limiting tumour cell proliferation. | Nat Commun | 2025 | https://conductscience.org/library/papers/41390489 | PubMed |
| 40936684 | Integration of single-cell and bulk RNA sequencing to identify unique tumor stem cells and construct novel prognostic markers for assessing ESCA prognosis and drug sensitivity. | Front Oncol | 2025 | https://conductscience.org/library/papers/40936684 | PubMed |
| 40040695 | Polyamine metabolism and anti-tumor immunity. | Front Immunol | 2025 | https://conductscience.org/library/papers/40040695 | PubMed |
| 39959839 | Integrated genomic analysis of the stemness index signature of mRNA expression predicts lung adenocarcinoma prognosis and immune landscape. | PeerJ | 2025 | https://conductscience.org/library/papers/39959839 | PubMed |
| 39934701 | Multi-omics analysis reveals the impact of YAP/TEAD4-mediated EIF5A1 expression on mitochondrial apoptosis and bladder cancer progression. | BMC Cancer | 2025 | https://conductscience.org/library/papers/39934701 | PubMed |
| 38276673 | Toxoplasma gondii eIF-5A Modulates the Immune Response of Murine Macrophages In Vitro. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/38276673 | PubMed |
| 38229033 | SUMOylation modulates eIF5A activities in both yeast and pancreatic ductal adenocarcinoma cells. | Cell Mol Biol Lett | 2024 | https://conductscience.org/library/papers/38229033 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36915194
GET https://conductscience.org/api/papers/v1/36915194/references?page=2